Semaphorins and their receptors in lung cancer.
暂无分享,去创建一个
[1] B. Lutz,et al. The Orthologous Human and Murine Semaphorin 6A-1 Proteins (SEMA6A-1/Sema6A-1) Bind to the Enabled/Vasodilator-stimulated Phosphoprotein-like Protein (EVL) via a Novel Carboxyl-terminal Zyxin-like Domain* , 2000, The Journal of Biological Chemistry.
[2] E. Gonos,et al. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients. , 2002, Anticancer research.
[3] M. Martín-Satué,et al. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display , 1999, Journal of surgical oncology.
[4] J. Klooster,et al. Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix , 2005, Molecular and Cellular Neuroscience.
[5] M. Tessier-Lavigne,et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function , 2003, Nature.
[6] H. Friess,et al. Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer , 2007, International journal of cancer.
[7] Michael J. Hansen,et al. Semaphorin 5A Is a Bifunctional Axon Guidance Cue Regulated by Heparan and Chondroitin Sulfate Proteoglycans , 2004, Neuron.
[8] I. Konishi,et al. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. , 2006, Human pathology.
[9] F. Peale,et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. , 2008, Cancer cell.
[10] Bernd Fritzsch,et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. , 2003, Developmental cell.
[11] Yusuke Nakamura,et al. Identification of semaphorin3B as a direct target of p53. , 2002, Neoplasia.
[12] P. Comoglio,et al. Interplay between scatter factor receptors and B plexins controls invasive growth , 2004, Oncogene.
[13] Min Lu,et al. Structure of the Semaphorin-3A Receptor Binding Module , 2003, Neuron.
[14] M. Shibuya,et al. Vascular Endothelial Growth Factor Receptor-1 and Neuropilin-2 Form Complexes* , 2001, The Journal of Biological Chemistry.
[15] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[16] D. Mukhopadhyay,et al. C terminus of RGS‐GAIP‐interacting protein conveys neuropilin‐1‐mediated signaling during angiogenesis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] Robert M. Gemmill,et al. WNT7a induces E-cadherin in lung cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] Thomas M. Jessell,et al. Semaphorin 3E and Plexin-D1 Control Vascular Pattern Independently of Neuropilins , 2005, Science.
[19] L. Ellis,et al. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. , 2008, Journal of the National Cancer Institute.
[20] J. Klingelhöfer,et al. Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. , 1998, Cancer research.
[21] P Giraud,et al. Chapter 44 – Non–Small Cell Lung Cancer , 2016 .
[22] H. Augustin,et al. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. , 2007, Cancer research.
[23] W. Shoji,et al. Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos , 2003, Development.
[24] M. Sekine,et al. Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1 , 2007, PLoS medicine.
[25] C. Demangel,et al. Identification of a peptide blocking vascular endothelial growth factor (VEGF)‐mediated angiogenesis , 2000, The EMBO journal.
[26] H. Klocker,et al. Plexin-B1 mutations in prostate cancer , 2007, Proceedings of the National Academy of Sciences.
[27] H. Osada,et al. CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells , 2007, Oncogene.
[28] M. Tessier-Lavigne,et al. Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III , 1997, Cell.
[29] U. Yazdani,et al. The semaphorins , 2006, Genome Biology.
[30] M. Crépin,et al. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. , 2006, Life sciences.
[31] G. Neufeld,et al. Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis , 2004, Cancer Research.
[32] G. Spraggon,et al. Crystal structure of the human neuropilin-1 b1 domain. , 2003, Structure.
[33] J. Minna,et al. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[34] Marina Ziche,et al. VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant , 2004, Cancer Research.
[35] C. Tse,et al. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line. , 2002, Cancer research.
[36] D. Mukhopadhyay,et al. Neuropilin-1 Modulates p53/Caspases Axis to Promote Endothelial Cell Survival , 2007, PloS one.
[37] S. Naylor,et al. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. , 1996, Genomics.
[38] J. Minna,et al. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] Leo Kinarsky,et al. Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. , 2007, Omics : a journal of integrative biology.
[40] Giorgio F. Gilestro,et al. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. , 2005, Cancer research.
[41] P. Circosta,et al. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes. , 2003, Blood.
[42] Lin Chen,et al. Expression of semaphorin 6D in gastric carcinoma and its significance. , 2006, World journal of gastroenterology.
[43] F. Cappuzzo,et al. Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[44] Franklin Peale,et al. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. , 2007, Cancer cell.
[45] G. Bismuth,et al. Controlling the immune system through semaphorins. , 2002, Science's STKE : signal transduction knowledge environment.
[46] M. Kreuter,et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. , 2004, The Journal of clinical investigation.
[47] M. Klagsbrun,et al. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis , 2008, Angiogenesis.
[48] Elisabeth Brambilla,et al. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines , 2003, The Journal of pathology.
[49] U. Weidle,et al. Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line. , 2003, Anticancer research.
[50] E. Brambilla,et al. Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration. , 2000, The American journal of pathology.
[51] T. Mikkelsen,et al. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway , 2007, Oncogene.
[52] E. Marinelli,et al. Tuftsin Binds Neuropilin-1 through a Sequence Similar to That Encoded by Exon 8 of Vascular Endothelial Growth Factor* , 2006, Journal of Biological Chemistry.
[53] D. Bouchier-Hayes,et al. Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia. , 2008, International journal of oncology.
[54] C. Marsit,et al. The race associated allele of Semaphorin 3B (SEMA3B) T415I and its role in lung cancer in African-Americans and Latino-Americans. , 2005, Carcinogenesis.
[55] K. Alitalo,et al. Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] H. Augustin,et al. Neuropilin‐1 and neuropilin‐2 enhance VEGF121 stimulated signal transduction by the VEGFR‐2 receptor , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] B. J. Limberg,et al. Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121 * , 2001, The Journal of Biological Chemistry.
[58] R. Gemmill,et al. Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells. , 2005, Neoplasia.
[59] S. Hirohashi,et al. Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Poo,et al. Plexins Are a Large Family of Receptors for Transmembrane, Secreted, and GPI-Anchored Semaphorins in Vertebrates , 1999, Cell.
[61] C. Tse,et al. Semaphorin 3 F Gene from Human 3 p 21 . 3 Suppresses Tumor Formation in Nude Mice 1 , 2002 .
[62] G. Neufeld,et al. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. , 2006, Blood.
[63] A. Elhabazi,et al. Biological Activity of Soluble CD100. I. The Extracellular Region of CD100 Is Released from the Surface of T Lymphocytes by Regulated Proteolysis1 , 2001, The Journal of Immunology.
[64] Atsushi Kumanogoh,et al. Semaphorins and their receptors in immune cell interactions , 2008, Nature Immunology.
[65] H. Arakawa,et al. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. , 2007, Cancer research.
[66] S. D. Fraser,et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. , 2004, Developmental cell.
[67] J. Gutkind,et al. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[68] G. Neufeld,et al. Gene expression pattern Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins , 2001 .
[69] T. Yagi,et al. Repulsive axon guidance molecule Sema3A inhibits branching morphogenesis of fetal mouse lung , 2000, Mechanisms of Development.
[70] J. Settleman,et al. p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling , 2005, Journal of Cell Science.
[71] S. Offermanns,et al. ErbB-2 and Met Reciprocally Regulate Cellular Signaling via Plexin-B1* , 2008, Journal of Biological Chemistry.
[72] 永井 英雅. CLCP1 interacts with semaphorin 4B and regulates motility of lung cancer cells , 2008 .
[73] M. Shibuya,et al. Neuropilin-1 Is a Placenta Growth Factor-2 Receptor* , 1998, The Journal of Biological Chemistry.
[74] Hong Zhang,et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion , 2005, Nature Neuroscience.
[75] G. Neufeld,et al. The neuropilins and their role in tumorigenesis and tumor progression. , 2006, Cancer letters.
[76] Christian Wiesmann,et al. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding , 2007, The EMBO journal.
[77] J. Bergh,et al. Homozygous deletions at 3p12 in breast and lung cancer , 1998, Oncogene.
[78] K. Guan,et al. Semaphorins command cells to move , 2005, Nature Reviews Molecular Cell Biology.
[79] Jacques J. Peschon,et al. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs , 2003, Nature.
[80] Y. Glinka,et al. Neuropilin-1 is a receptor for transforming growth factor β-1, activates its latent form, and promotes regulatory T cell activity , 2008, Journal of leukocyte biology.
[81] P. Carmeliet,et al. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment , 2008, The Journal of experimental medicine.
[82] F. Rossi,et al. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis , 2007, BMC Developmental Biology.
[83] Masato Nakamura,et al. Neuropilin 1 and neuropilin 2 co‐expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma , 2002, Cancer.
[84] J. Roche,et al. Semaphorin signaling in the immune system. , 2007, Advances in Experimental Medicine and Biology.
[85] H. Katoh,et al. The Semaphorin 4D Receptor Plexin-B1 Is a GTPase Activating Protein for R-Ras , 2004, Science.
[86] D. Guidolin,et al. Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. , 2006, Blood.
[87] H. Bellamy,et al. Structural basis for ligand and heparin binding to neuropilin B domains , 2007, Proceedings of the National Academy of Sciences.
[88] F. Bussolino,et al. Besides adhesion: new perspectives of integrin functions in angiogenesis. , 2008, Cardiovascular research.
[89] Akira Masuda,et al. Significant up-regulation of a novel gene, CLCP1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo , 2002, Oncogene.
[90] Jeffery G Herman,et al. Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells. , 2007, International journal of oncology.
[91] T. Veikkola,et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[92] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[93] H. Drabkin,et al. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. , 2003, Neoplasia.
[94] M. Narazaki,et al. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. , 2008, Blood.
[95] C. Croce,et al. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. , 2003, Cancer research.
[96] Chan Zeng,et al. Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non–Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels , 2006, Clinical Cancer Research.
[97] S. Kenwrick,et al. Cis and trans interactions of L1 with neuropilin‐1 control axonal responses to semaphorin 3A , 2002, The EMBO journal.
[98] J. Gutkind,et al. MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D* , 2007, Journal of Biological Chemistry.
[99] G. Neufeld,et al. Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis* , 2007, Journal of Biological Chemistry.
[100] M. Wu,et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells , 2008, Oncogene.
[101] M. West,et al. Gene expression profiling and genetic markers in glioblastoma survival. , 2005, Cancer research.
[102] S. Naylor,et al. An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. , 1996, Oncogene.
[103] S. Soker,et al. Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility , 1999, The Journal of cell biology.
[104] J. Basile,et al. Semaphorins in vascular development and head and neck squamous cell carcinoma-induced angiogenesis. , 2008, Oral oncology.
[105] T. Kitsukawa,et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[106] P. Comoglio,et al. Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. , 1999, Experimental cell research.
[107] Franklin Peale,et al. Neuropilin-1 Binds to VEGF121 and Regulates Endothelial Cell Migration and Sprouting* , 2007, Journal of Biological Chemistry.
[108] U. Hellman,et al. Differential Binding of Vascular Endothelial Growth Factor B Splice and Proteolytic Isoforms to Neuropilin-1* , 1999, The Journal of Biological Chemistry.
[109] M. Reed,et al. Neuropilins in physiological and pathological angiogenesis , 2007, The Journal of pathology.
[110] E. Bruyneel,et al. Inhibition of vascular endothelial growth factor (VEGF)-165 and semaphorin 3A–mediated cellular invasion and tumor growth by the VEGF signaling inhibitor ZD4190 in human colon cancer cells and xenografts , 2006, Molecular Cancer Therapeutics.
[111] Enrique Alvarez,et al. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis , 2005, Cancer biology & therapy.
[112] J. Sanes,et al. Dual Functional Activity of Semaphorin 3B Is Required for Positioning the Anterior Commissure , 2005, Neuron.
[113] Thomas M. Jessell,et al. Gating of Sema3E/PlexinD1 Signaling by Neuropilin-1 Switches Axonal Repulsion to Attraction during Brain Development , 2007, Neuron.
[114] G. Sozzi. Molecular biology of lung cancer. , 2001, European journal of cancer.
[115] G. Freeman,et al. The leukocyte semaphorin CD100 is expressed in most T-cell, but few B-cell, non-Hodgkin's lymphomas. , 1998, The American journal of pathology.
[116] G. Ito,et al. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. , 2005, Cancer letters.
[117] M. Lohrum,et al. The chemorepulsive activity of secreted semaphorins is regulated by furin‐dependent proteolytic processing , 1997, The EMBO journal.
[118] W. Franklin,et al. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. , 1996, Oncogene.
[119] B. J. Limberg,et al. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). , 2001, The Journal of biological chemistry.
[120] A. Kolodkin,et al. Semaphorin regulation of cellular morphology. , 2007, Annual review of cell and developmental biology.
[121] T. Kitsukawa,et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. , 1995, Development.
[122] Wing-Kai Chan,et al. Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer , 2007, Clinical Cancer Research.
[123] S. Petersen,et al. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization , 2001, British Journal of Cancer.
[124] L. Ellis. The role of neuropilins in cancer , 2006, Molecular Cancer Therapeutics.
[125] T. Kijima,et al. Cloning and tissue expression of cDNAs from chromosome 5q21–22 which is frequently deleted in advanced lung cancer , 1998, Human Genetics.
[126] Giorgio F. Gilestro,et al. The Semaphorin 4D receptor controls invasive growth by coupling with Met , 2002, Nature Cell Biology.
[127] M. Tessier-Lavigne,et al. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. , 2007, Journal of molecular biology.
[128] M. Karkkainen,et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. , 2002, Development.
[129] J. Minna,et al. Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. , 2005, Biochimica et biophysica acta.
[130] E. Sulpice,et al. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. , 2008, Blood.
[131] M. Faronato,et al. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. , 2006, Blood.
[132] E. Petricoin,et al. Drosophila screening model for metastasis: Semaphorin 5c is required for l(2)gl cancer phenotype , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[133] C. Tse,et al. Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice. , 2002, Cancer research.
[134] J. Minna,et al. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[135] J. Teichman,et al. Semaphorin 3C regulates endothelial cell function by increasing integrin activity , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[136] K. Mikoshiba,et al. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[137] V. Devita,et al. Cancer : Principles and Practice of Oncology , 1982 .
[138] H. Drabkin,et al. Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. , 2005, Neoplasia.
[139] M. Klagsbrun,et al. Targeting endothelial and tumor cells with semaphorins , 2007, Cancer and Metastasis Reviews.
[140] H. Bokhoven,et al. Plexin D 1 Expression Is Induced on Tumor Vasculature and Tumor Cells : A Novel Target for Diagnosis and Therapy ? , 2005 .
[141] J. Minna,et al. Semaphorin 3 B ( SEMA 3 B ) induces apoptosis in lung and breast cancer , whereas VEGF 165 antagonizes this effect , 2004 .
[142] S. Deaglio,et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. , 2005, Blood.
[143] D. Aunis,et al. Transmembrane domain interactions control biological functions of neuropilin-1. , 2007, Molecular biology of the cell.
[144] David C West,et al. Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2* , 2005, Journal of Biological Chemistry.
[145] Takaaki Ito,et al. Diverse gene expression and function of semaphorins in developing lung: positive and negative regulatory roles of semaphorins in lung branching morphogenesis , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[146] Alex L Kolodkin,et al. Neuropilin Is a Semaphorin III Receptor , 1997, Cell.
[147] Alex L Kolodkin,et al. Neuropilin-2 Is a Receptor for Semaphorin IV Insight into the Structural Basis of Receptor Function and Specificity , 1998, Neuron.
[148] B. Eickholt,et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. , 2003, Cancer research.
[149] R. Strausberg,et al. A preliminary transcriptome map of non-small cell lung cancer. , 2002, Cancer research.
[150] M. Devocelle,et al. A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells , 2005, British Journal of Cancer.
[151] A. Procopio,et al. Cross‐talk between vascular endothelial growth factor and semaphorin‐3A pathway in the regulation of normal and malignant mesothelial cell proliferation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[152] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[153] P. Frankel,et al. Neuropilins: structure, function and role in disease. , 2008, The Biochemical journal.
[154] T. Yagi,et al. A requirement for neuropilin-1 in embryonic vessel formation. , 1999, Development.
[155] Chi-Ying F. Huang,et al. Collapsin response mediator protein-1: A novel invasion-suppressor gene , 2003, Clinical & Experimental Metastasis.
[156] M. Korc,et al. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. , 2007, Cancer research.